<bill session="114" type="s" number="3176" updated="2018-06-02T07:47:14Z">
  <state datetime="2016-07-13">REFERRED</state>
  <status>
    <introduced datetime="2016-07-13"/>
  </status>
  <introduced datetime="2016-07-13"/>
  <titles>
    <title type="short" as="introduced">STAAR Act</title>
    <title type="short" as="introduced">Strategies to Address Antibiotic Resistance Act</title>
    <title type="official" as="introduced">A bill to amend the Public Health Service Act to enhance efforts to address antibiotic resistance, and for other purposes.</title>
    <title type="display">STAAR Act</title>
  </titles>
  <sponsor bioguide_id="B000944"/>
  <cosponsors/>
  <actions>
    <action datetime="2016-07-13">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2016-07-13" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Advisory bodies"/>
    <term name="Congressional oversight"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Government information and archives"/>
    <term name="Health facilities and institutions"/>
    <term name="Health information and medical records"/>
    <term name="Health promotion and preventive care"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Medical research"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2016-07-13T04:00:00Z" status="Introduced in Senate">Strategies to Address Antibiotic Resistance Act or the STAAR Act

This bill amends the Public Health Service Act to revise provisions regarding the Antimicrobial Resistance Task Force.

The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria must provide advice, information, and recommendations to the Department of Health and Human Services.

The Centers for Disease Control and Prevention (CDC) must carry out activities to collect data on antibiotic resistance, including assessing conditions and outcomes related to antibacterial resistance and working with others to obtain human antibiotic drug consumption data.

The CDC must establish Antibiotic Resistance Surveillance and Laboratory Network sites, including to monitor antibiotic-resistant bacteria, describe and respond to outbreaks, and evaluate resistance testing methods.

The National Institute of Allergy and Infectious Diseases must maintain: (1) a Clinical Trials Network on Antibacterial Resistance, and (2) a leadership group to advance a clinical research agenda to address antibacterial resistance.

The CDC must work with state and local health departments to support efforts by groups of health care facilities to prevent the spread of antibiotic-resistant bacteria.

The CDC and the epicenters participating in the Prevention Epicenters Program must work with others to: (1) evaluate prevention programs and interventions to limit infections in health care facilities, and (2) facilitate research on the prevention and control of resistant organisms. The CDC must use research from the epicenters to create and disseminate educational materials for use in health care facilities.</summary>
  <committee-reports/>
</bill>
